$AERT
Aeries Technology, Inc. Stock $aert

$aert Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000182912624006527 Filed on September 27, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2024
Revenue	$16.87M	$19.70M	$72.51M
YoY Change			36.55%
Cost Of Revenue	$13.30M	$13.38M	$50.87M
YoY Change	4.27%		28.97%
Gross Profit	$3.575M	$6.324M	$21.64M
YoY Change	-25.89%		58.46%
Gross Profit Margin	21.19%	32.1%	29.85%
Selling, General & Admin	$7.670M	$6.333M	$18.65M
YoY Change	380.13%	178.82%	64.7%
% of Gross Profit	214.55%	100.14%	86.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$371.0K	$348.0K	$1.352M
YoY Change	11.08%		15.36%
% of Gross Profit	10.38%	5.5%	6.25%
Operating Expenses	$7.670M	$6.333M	$18.65M
YoY Change	380.13%	178.82%	64.7%
Operating Profit	-$4.095M	-$9.000K	$2.987M
YoY Change	156.34%	-99.6%	28.14%
Interest Expense	$135.0K	$32.47M	$462.0K
YoY Change	78.52%	4292.5%	7600.0%
% of Operating Profit			15.47%
Other Income/Expense, Net	$1.263M	$90.00K	$16.14M
YoY Change			3662.24%
Pretax Income	-$2.832M	$32.55M	$19.13M
YoY Change	86.09%	-2224.72%	591.5%
Income Tax	-$526.0K	$417.0K	$1.871M
% Of Pretax Income		1.28%	9.78%
Net Earnings	-$2.280M	$30.83M	$17.26M
YoY Change	49.82%	-2112.12%	1093.36%
Net Earnings / Revenue	-13.51%	156.46%	23.8%
Basic Earnings Per Share	-$0.05		$0.91
Diluted Earnings Per Share	-$0.05	$1.89	$0.91
COMMON SHARES
Basic Shares Outstanding	44.50M shares		15.53M shares
Diluted Shares Outstanding	44.36M shares

Balance Sheet

Concept	2024 Q3	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.627M	$2.084M	$2.084M
YoY Change	43027.23%	17636.17%	84.26%
Cash & Equivalents	$3.627M	$2.084M	$2.084M
Short-Term Investments
Other Short-Term Assets	$7.343M	$6.995M	$2.088M
YoY Change	877199.88%	119780.03%	-18.05%
Inventory			$728.0K
Prepaid Expenses		$878.0K
Receivables	$18.48M	$23.76M	$23.76M
Other Receivables	$0.00	$0.00	$4.179M
Total Short-Term Assets	$29.45M	$32.84M	$32.84M
YoY Change	59880.85%	11530.61%	59.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.728M	$3.579M	$10.90M
YoY Change	-60.87%	14.53%	24.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.717M	$1.612M	$1.612M
YoY Change	-96.57%	-99.32%	3.07%
Other Assets	$4.683M	$2.129M	$4.062M
YoY Change	16.12%	-5.75%	16.19%
Total Long-Term Assets	$22.51M	$16.57M	$16.57M
YoY Change	-54.97%	-93.01%	19.98%
TOTAL ASSETS
Total Short-Term Assets	$29.45M	$32.84M	$32.84M
Total Long-Term Assets	$22.51M	$16.57M	$16.57M
Total Assets	$51.96M	$49.41M	$49.41M
YoY Change	3.83%	-79.19%	43.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.330M	$6.616M	$6.616M
YoY Change	15.4%	17.23%	167.42%
Accrued Expenses	$4.257M	$4.892M	$10.09M
YoY Change	6736.69%	7756.49%	74.28%
Deferred Revenue
YoY Change
Short-Term Debt	$4.482M	$6.778M	$6.765M
YoY Change	703.5%	1470.11%	395.97%
Long-Term Debt Due	$1.514M	$1.440M	$307.0K
YoY Change	11546.15%	48.61%	-4.06%
Total Short-Term Liabilities	$39.22M	$38.13M	$38.13M
YoY Change	317.87%	482.37%	204.46%
LONG-TERM LIABILITIES
Long-Term Debt	$1.514M	$1.440M	$1.440M
YoY Change			19.6%
Other Long-Term Liabilities	$4.462M	$3.948M	$10.93M
YoY Change	345.47%	75.94%	55.39%
Total Long-Term Liabilities	$5.976M	$5.388M	$12.37M
YoY Change	496.62%	140.11%	50.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.22M	$38.13M	$38.13M
Total Long-Term Liabilities	$5.976M	$5.388M	$12.37M
Total Liabilities	$53.27M	$50.59M	$61.65M
YoY Change	412.84%	475.47%	177.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.68M	-$11.67M
YoY Change	180.08%	38.76%
Common Stock		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.316M	-$12.24M	-$12.24M
YoY Change
Total Liabilities & Shareholders Equity	$51.96M	$49.41M	$49.41M
YoY Change	3.83%	-79.19%	43.64%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$2.280M	$30.83M	$17.26M
YoY Change	49.82%	-2112.12%	1093.36%
Depreciation, Depletion And Amortization	$371.0K	$348.0K	$1.352M
YoY Change	11.08%		15.36%
Cash From Operating Activities	$1.925M	-$4.324M	-$4.299M
YoY Change	-5856.58%	-3040.26%	-303.65%
INVESTING ACTIVITIES
Capital Expenditures	$612.0K	$458.0K	$1.520M
YoY Change	28.57%		-5.0%
Acquisitions
YoY Change
Other Investing Activities	$232.0K	-$212.0K	-$220.0K
YoY Change			-611.63%
Cash From Investing Activities	-$380.0K	-$670.0K	-$1.740M
YoY Change			11.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.136M	582.0K	$7.056M
YoY Change		-417.28%	2700.0%
NET CHANGE
Cash From Operating Activities	1.925M	-4.324M	-$4.299M
Cash From Investing Activities	-380.0K	-670.0K	-$1.740M
Cash From Financing Activities	-2.136M	582.0K	$7.056M
Net Change In Cash	-591.0K	-4.412M	$953.0K
YoY Change	1667.34%	12029.21%	18.24%
FREE CASH FLOW
Cash From Operating Activities	$1.925M	-$4.324M	-$4.299M
Capital Expenditures	$612.0K	$458.0K	$1.520M
Free Cash Flow	$1.313M	-$4.782M	-$5.819M
YoY Change	-357.73%		-1238.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001853044
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet		usd
CY2023Q1	aert	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability		usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability		usd
CY2023	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
CY2023	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests		usd
CY2023	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests		usd
CY2024	aert	Reclassification Of Negative Additional Paidin Capital ReclassificationOfNegativeAdditionalPaidinCapital		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024	aert	Impairment In Value Of Investments ImpairmentInValueOfInvestments		usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2023	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
CY2023	aert	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable		usd
CY2023	aert	Payment Of Promissory Note Liability PaymentOfPromissoryNoteLiability		usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets		usd
CY2023	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfClassOrdinarySharesToVendors		usd
CY2023	aert	Assumption Of Net Liabilities From Business Combination AssumptionOfNetLiabilitiesFromBusinessCombination		usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate		usd
CY2024	aert	Income Tax Reconciliation Nontaxable Income IncomeTaxReconciliationNontaxableIncome		usd
CY2023	aert	Income Tax Reconciliation Nontaxable Income IncomeTaxReconciliationNontaxableIncome		usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2024	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	49900000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44500426	shares
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Auditor Name AuditorName	Manohar Chowdhry & Associates
CY2024	dei	Auditor Firm AuditorFirmId	5341
CY2024	dei	Auditor Location AuditorLocation	Chennai, India
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2084000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1131000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	1263000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	23757000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	13416000	usd
CY2024Q1	aert	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	1000	usd
CY2023Q1	aert	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	0	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6995000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4117000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	1921000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	32836000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	20585000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3579000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3125000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7318000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5627000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1933000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1237000	usd
CY2024Q1	aert	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	126000	usd
CY2023Q1	aert	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	0	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	1612000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	1564000	usd
CY2024Q1	aert	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	1000	usd
CY2023Q1	aert	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	0	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2129000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2259000	usd
CY2024Q1	us-gaap	Assets Assets	49407000	usd
CY2023Q1	us-gaap	Assets Assets	34397000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6616000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2474000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3119000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2823000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2080000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1648000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	6778000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1376000	usd
CY2024Q1	aert	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability	10244000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9288000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4201000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38125000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12522000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1440000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	969000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5615000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4261000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1367000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	92000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	168000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3948000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3008000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	50587000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	20928000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	734000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7221000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-574000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1349000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11668000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6318000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-12240000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12190000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	10326000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1279000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1914000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49407000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34397000	usd
CY2024	us-gaap	Revenues Revenues	72509000	usd
CY2023	us-gaap	Revenues Revenues	53099000	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	50868000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	39442000	usd
CY2024	us-gaap	Gross Profit GrossProfit	21641000	usd
CY2023	us-gaap	Gross Profit GrossProfit	13657000	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18654000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11326000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	18654000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	11326000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	2987000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2331000	usd
CY2024	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability	14765000	usd
CY2024	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	1402000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	275000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	191000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16140000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	435000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19127000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2766000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1871000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1060000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	17256000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1706000	usd
CY2024	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	202000	usd
CY2023	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	260000	usd
CY2024	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests	1397000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15657000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1446000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15532382	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91
CY2024	us-gaap	Profit Loss ProfitLoss	17256000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1706000	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	185000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	709000	usd
CY2024	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	12000	usd
CY2023	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-117000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-173000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-826000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17083000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	880000	usd
CY2024	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	-180000	usd
CY2023	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	-139000	usd
CY2024	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests	-1407000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15496000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	741000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2024	aert	Transition Period Adjustment Pursuant To Asc326 Net Of Tax TransitionPeriodAdjustmentPursuantToAsc326NetOfTax	-223000	usd
CY2024	aert	Adjusted Balances AdjustedBalances	13246000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1626000	usd
CY2024	aert	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	-10000	usd
CY2024	aert	Share In Premerger Net Income ShareInPremergerNetIncome	1616000	usd
CY2024	aert	Share In Premerger Other Comprehensive Income ShareInPremergerOtherComprehensiveIncome	-191000	usd
CY2024	aert	Impact Of Reverse Recapitalization Refer Note2 ImpactOfReverseRecapitalizationReferNote2	-43609000	usd
CY2024	aert	Settlement Of Accounts Payable Through Issuance Of Shares SettlementOfAccountsPayableThroughIssuanceOfShares	903000	usd
CY2024	aert	Net Income For Period Post Business Combination Upto Redeemable Nci Reclass NetIncomeForPeriodPostBusinessCombinationUptoRedeemableNciReclass	12484000	usd
CY2024	aert	Other Comprehensive Loss Post Business Combination Upto Redeemable Nci Reclass OtherComprehensiveLossPostBusinessCombinationUptoRedeemableNciReclass	7000	usd
CY2024	aert	Reclassification Of Redeemable Nci To Nci ReclassificationOfRedeemableNciToNci	10254000	usd
CY2024	aert	Net Income For Period Post Business Combination Post Redeemable Nci Reclass NetIncomeForPeriodPostBusinessCombinationPostRedeemableNciReclass	1759000	usd
CY2024	aert	Other Comprehensive Loss Post Business Combination Post Redeemable Nci Reclass OtherComprehensiveLossPostBusinessCombinationPostRedeemableNciReclass	1000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1914000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8696000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1706000	usd
CY2023	aert	Other Comprehensive Loss OtherComprehensiveLoss	-826000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3805000	usd
CY2023	aert	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	88000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	17256000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1706000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1352000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1172000	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1626000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3805000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-718000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-161000	usd
CY2024	aert	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	196000	usd
CY2023	aert	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	130000	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1098000	usd
CY2024	aert	Gain On Lease Termination GainOnLeaseTermination	13000	usd
CY2023	aert	Gain On Lease Termination GainOnLeaseTermination	25000	usd
CY2024	aert	Sundry Balances Written Back SundryBalancesWrittenBack	-48000	usd
CY2023	aert	Sundry Balances Written Back SundryBalancesWrittenBack	-36000	usd
CY2024	aert	Unrealized Exchange Gain Loss UnrealizedExchangeGainLoss	-26000	usd
CY2023	aert	Unrealized Exchange Gain Loss UnrealizedExchangeGainLoss	6000	usd
CY2023	aert	Impairment In Value Of Investments ImpairmentInValueOfInvestments	24000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-54000	usd
CY2024	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-14765000	usd
CY2024	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	1402000	usd
CY2024	aert	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable	48000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11741000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6123000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	340000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1199000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1839000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6113000	usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-312000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	801000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-568000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1020000	usd
CY2024	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	323000	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	898000	usd
CY2024	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2378000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	838000	usd
CY2024	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	1953000	usd
CY2023	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	6425000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	999000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	751000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4299000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2111000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1520000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1600000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	usd
CY2024	aert	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	2325000	usd
CY2023	aert	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	813000	usd
CY2024	aert	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	2094000	usd
CY2023	aert	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	844000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1740000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1557000	usd
CY2024	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	2545000	usd
CY2023	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1184000	usd
CY2024	aert	Payment Of Promissory Note Liability PaymentOfPromissoryNoteLiability	1500000	usd
CY2024	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	448000	usd
CY2024	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	882000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	368000	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	391000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	229000	usd
CY2024	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	391000	usd
CY2023	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	390000	usd
CY2024	aert	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	2297000	usd
CY2023	aert	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	769000	usd
CY2024	aert	Net Changes In Net Shareholders Investment NetChangesInNetShareholdersInvestment	10000	usd
CY2023	aert	Net Changes In Net Shareholders Investment NetChangesInNetShareholdersInvestment	-88000	usd
CY2024	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	8666000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7056000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-64000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-26000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	953000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	780000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1131000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	351000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2084000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1131000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	465000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	273000	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1008000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1229000	usd
CY2024	aert	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	663000	usd
CY2023	aert	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	1189000	usd
CY2024	aert	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	313000	usd
CY2023	aert	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	164000	usd
CY2024	aert	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	41000	usd
CY2023	aert	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	25000	usd
CY2024	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfClassOrdinarySharesToVendors	855000	usd
CY2024	aert	Assumption Of Net Liabilities From Business Combination AssumptionOfNetLiabilitiesFromBusinessCombination	38994000	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zIOtznhier9g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 - <span id="xdx_829_zHLTd94IxbSk">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeries Technology, Inc. (formerly Worldwide Webb Acquisition Corp. (“WWAC”), formed in the Cayman Islands on March 5, 2021) and its subsidiaries, excluding the fintech and investing business activities, is herein referred to as the “Company”, “ATI”, the “registrant”, “us,” “we” and “our” in these consolidated financial statements. Aark Singapore Pte. Ltd. and its subsidiaries (“AARK”), excluding the fintech and investing business activities, is herein referred to as the “Carve-out Entity”. The Company is a global provider of professional and management services and technology consulting, specializing in the establishment and management of dedicated delivery centers known as “Global Capability Centers” (“GCCs”) for portfolio companies of private equity firms and mid-market enterprises. Our engagement models are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client’s business operations. The Company has subsidiaries in India, Mexico, Singapore, UAE and the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in Fiscal Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 6, 2023, the Company’s Board of Directors approved a change in the Company’s fiscal year end from December 31 to March 31. The Company’s latest fiscal year ran from April 1, 2023, through March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Demerger and Business Combination</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2023, WWAC entered into the Business Combination Agreement (the “Merger Agreement,” and the transactions contemplated therein, the “Business Combination”), with WWAC Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and a direct wholly-owned subsidiary of WWAC (“Amalgamation Sub”), and Aark Singapore Pte. Ltd. a Singapore private company limited by shares (“AARK”) (together with WWAC and Amalgamation Sub, the “Parties” and individually, a “Party”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AARK was engaged in management consulting, fintech and investing business. However, only the management consulting business was subject to the Merger Agreement and therefore in connection with the Business Combination, AARK entered into a Demerger Agreement with Aarx Singapore Pte. Ltd. and their respective shareholders on March 25, 2023 to spin off the fintech business which was a part of AARK but not subject to the Merger Agreement. Subsequently, the AARK Board of Directors ratified two resolutions on May 24, 2023. These resolutions effectively spun off the investing business which was part of AARK but not subject to the Merger Agreement. These transactions will collectively be referred to as “Demerger Transactions”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Merger Agreement, all AARK ordinary shares that were issued and outstanding prior to the effective time of the Business Combination remained issued and outstanding following the Business Combination and continued to be held by the Sole Shareholder (as defined below) of AARK. The Company issued a Class V ordinary share to NewGen Advisors and Consultants DWC-LLC (“NewGen”). NewGen is a business associate of Mr. Raman Kumar (“Sole Shareholder”). NewGen has agreed to hold the Class V ordinary share to protect the interest of the Sole Shareholder, in the event of certain events, including a hostile takeover or the appointment or removal of directors at ATI level. While the Class V ordinary share does not carry any direct economic rights, it does carry voting rights equal to 26% which will ratchet up to 51% voting rights upon occurrence of extraordinary events at the ATI level. All of the shares of Amalgamation Sub that were issued and outstanding immediately prior to the effective time of the Business Combination were converted into a number of newly issued AARK ordinary shares. In accordance with principles of Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”) and based on the economic interest held by the shareholders post the Business Combination as well as the underlying rights, it was assessed that AARK is the accounting acquirer and WWAC is the accounting acquiree. The Business Combination closed on November 6, 2023 (“Closing Date”) and resulted in ATI owning <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_c20231106__srt--OwnershipAxis__custom--AARKMember_pdd" title="Ownership, percentage">38.24%</span> of the issued and outstanding shares of AARK and the Sole Shareholder of AARK owning the balance <span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_c20231106__srt--OwnershipAxis__custom--AARKShareholdersMember_pdd" title="Ownership, percentage">61.76%</span>. Pursuant to the Business Combination, ATI has a right to appoint two out of the three directors on the Board of AARK and therefore has an ability to control the activities undertaken by AARK in ordinary course of business, resulting in AARK being classified as a subsidiary of ATI. Finally, the Business Combination has been accounted for as reverse recapitalization. Refer to the section <i>“Reverse Recapitalization”</i> below for details.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse Recapitalization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As mentioned above – <i>Demerger and Business Combination</i>, the Business Combination was closed on November 6, 2023 and has been accounted for as a reverse recapitalization because AARK has been determined to be the accounting acquirer under ASC 805 based on the evaluation of the following facts and circumstances taken into consideration:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sole Shareholder, who controlled AARK prior to the Business Combination, will retain a majority of the outstanding shares of ATI after giving effect to the Exchange Agreements. The Exchange Agreements are further discussed in Note 22;</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AARK has the ability to elect a majority of the members of ATI’s governing body;</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AARK’s executive team makes up the executive team of ATI;</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AARK represents an operating entity (group) with operating assets, revenues, and earnings significantly larger than WWAC.</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under a reverse recapitalization, while WWAC was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of pre-combination AARK issuing stock for the net assets of WWAC, accompanied by a recapitalization. The net assets of WWAC have been stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of pre-combination AARK and relate to the management consulting business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately following the Business Combination, there were <span id="xdx_907_eus-gaap--SharesOutstanding_iI_pip0_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zllh9OBwabo8" title="Shares Outstanding">15,257,666</span> Class A ordinary shares outstanding with a par value of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQt55fkiRrS2" title="Common stock, par value">0.0001</span> per share. Additionally, there were <span id="xdx_904_ecustom--PurchaseOfAdditionalShares_pip0_c20230401__20240331__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember_z7xrHFbnGnu7" title="Purchase of additional shares">9,527,810</span> Private Placement Warrants (defined below) and <span id="xdx_902_ecustom--PurchaseOfAdditionalShares_pip0_c20230401__20240331__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember_zkyBVCDJfd4" title="Purchase of additional shares">11,499,991</span> Public Warrants (defined below) outstanding with a right to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_c20240331_z9M2P0a0KE11" title="Warrants outstanding">21,027,801</span> Class A ordinary shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon closing of the Business Combination, the total number of ATI’s Class A ordinary shares issued and outstanding was <span id="xdx_90D_eus-gaap--SharesIssued_iI_pip0_c20240331__us-gaap--StatementEquityComponentsAxis__custom--ClassAOrdinarySharesMember_zpImv7OYwn76" title="Shares issued"><span id="xdx_901_eus-gaap--SharesOutstanding_iI_pip0_c20240331__us-gaap--StatementEquityComponentsAxis__custom--ClassAOrdinarySharesMember_zbX4QMIHFymk" title="Shares Outstanding">15,257,666</span></span>. Further, certain Class A ordinary shareholders entered into non-redemption agreements executed on November 3, 2023 and November 5, 2023, to reverse redemptions for an aggregate of 1,652,892 Class A ordinary shares while waiving their right to receive any “Bonus Shares” issued under the Merger Agreement. In connection with the closing, holders of <span id="xdx_909_ecustom--RedemptionOfShares_iI_pip0_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z99U04W0nXm6" title="Redemption of shares">2,697,052</span> Class A ordinary shares of WWAC were redeemed at a price per share of approximately $10.69. AARK incurred approximately $<span id="xdx_90F_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240331_zyxjbCI8o2Kf" title="Transaction costs relating to business combination">3,697</span> in transaction costs relating to the Business Combination and recorded those costs against additional paid-in capital in the consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of Class A ordinary shares issued and outstanding immediately following the consummation of the Business Combination were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfconsummationOfBusinessCombinationTableTextBlock_pn3n3_zixrxR5ktHUa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Nature of Operations (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span><span id="xdx_8B0_zpx59rQT3gLl" style="display: none">Schedule of consummation of business combination</span></span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_497_20240331_zeQFSx8EI3i5" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--PublicShareholdersRedeemableClassOrdinarySharesIncludingBonusShares_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Shareholders (Redeemable Class A ordinary shares), including Bonus Shares<sup id="xdx_F45_zYJhEcKiPKX5">(1)</sup></span></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">3,157,469</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders_iI_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by Worldwide Webb Acquisition Sponsor, LLC (the “Sponsor”) and other initial holders<sup id="xdx_F40_znCTXPc9t2Q5">(2)(3)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,750,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--SharesHeldByInnovoConsultancyDmcc_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by Innovo Consultancy DMCC<sup id="xdx_F42_zBlllETNlxE6">(4)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,638,530</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SharesHeldByFpaHolders_iI_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by FPA Holders<sup id="xdx_F4C_zrpjbtAxJa0g">(5)</sup></span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,711,667</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--SharesIssued_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup id="xdx_F4C_zyoTGZbOjF7e">(6)</sup></b></span></td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">15,257,666</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F0C_zg7UZb2BHlh6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F19_zmCrUFnoRx3a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 87,133 Bonus Shares issued to the Company’s public shareholders and 1,024,335 “Extension Shares” issued to certain holders of Class A ordinary shares (the “Holders”) in accordance with the Non-Redemption Agreement entered into between WWAC, the Sponsor, and the Holders of Class A ordinary shares. Also includes 288,333 shares purchased by the Forward Purchase Agreement holders in the open market or via redemption reversals prior to the consummation of the Business Combination.</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F08_z90G7cOAhy45" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F1A_zT8dxvU1iI6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 1,500,000 Class A ordinary shares issued to the Sponsor and 1,250,000 Class A ordinary shares issued to certain anchor investors upon conversion of Class B ordinary shares concurrently with the consummation of the Business Combination. 3,000,000 Class B ordinary shares were forfeited by the Sponsor upon the consummation of the Business Combination.</span></td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F0B_zvhRurGjEyZ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F1E_zU9unD8Q9Zwb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not include (i) 1,500,000 Class B ordinary shares forfeited upon the consummation of the Business Combination, or (ii) 1,500,000 Class B ordinary shares forfeited pursuant to a Support Agreement with the Sponsor.</span></td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F02_zdMvZaG30Hij" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F10_zODWhuwbz0n7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 3,000,000 Class A Shares reissued against 3,000,000 Class B Shares forfeited by the Sponsor upon consummation of the Business Combination as per (2) above, and (ii) 2,638,530 remaining Bonus Shares issued to Innovo.</span></td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F01_zFmQdoiyaYgc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F13_zIFe2Vlpy2Kh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents a new issuance of Class A ordinary shares to the Forward Purchase Agreement holders in accordance with the Forward Purchase Agreement.</span></td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; vertical-align: top; width: 0in"></td> <td style="text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_F01_zVKwVPj13nte" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td> <td style="vertical-align: top; text-align: justify"><span id="xdx_F15_zOq9Dn8bSdJ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does not include 10,000 AARK ordinary shares and 655,788 ordinary shares of Aeries Technology Group Business Accelerators Private Limited that represent noncontrolling interest in AARK. These shares will be exchangeable (together with the proportionate reduction in the voting power of the Class V ordinary share, and in the case of the exchange of all AARK ordinary shares, the forfeiture and cancellation of the Class V ordinary share) into shares in ATI in connection with the Exchange Agreements, which is further discussed in Note 19.</span></td> </tr> </table> <p id="xdx_8AF_zh7i4J2G1Mp3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the elements of the Business Combination to the change in net shareholders’ investment and additional paid-in capital on the consolidated statement of changes in redeemable noncontrolling interest and shareholders’ equity (deficit) for the year ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfReconcilesOfBusinessCombinationTableTextBlock_pn3n3_zLGpGvDW8Ttk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Nature of Operations (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span><span id="xdx_8B4_z8Z3hqI2qc95" style="display: none">Schedule of reconciles of business combination</span></span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_493_20230401__20240331_zC5r22DnvfW7" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Schedule of cash and net liabilities assumed pursuant to Business Combination</td> <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td> <td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40B_ecustom--BalanceInCompanyTrustAccount_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">Balance in Company trust account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">40,402</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--OutflowOnAccountOfRedemptionPayments_iN_pn3n3_di_zJtYSnH0Ohhi" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Outflow on account of redemption payments</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(18,795</td> <td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--PrepaymentForRecycleShareUnderForwardPurchaseAgreement_iN_pn3n3_di_zBqKy56TxlF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Prepayment for recycle share under forward purchase agreement</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(3,083</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--LessPaymentsUnderNonredemptionAgreements_iN_pn3n3_di_zxmeJOjntOS1" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Payments under Non-redemption agreements</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(9,672</td> <td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--PaymentToContinentalStockTransferForServicesProvidedInRelationToBusinessCombination_iN_pn3n3_di_zXZV64PueEFi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Payment to Continental Stock Transfer for services provided in relation to the Business Combination</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(186</td> <td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--NetCashAcquiredInBusinessCombination_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left">Net cash acquired in Business Combination</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: right">8,666</td> <td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--AssumedNetLiabilitiesOfAtiOnClosingDate_iN_pn3n3_di_zBHRr8mJwcEi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Assumed net liabilities of ATI on Closing Date<sup id="xdx_F42_zpnLRpEt2dZ7">(1)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(38,994</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--PrecombinationTransactionCosts_iN_pn3n3_di_z3w3pBeNHkTc" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Pre-combination transaction costs</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(3,697</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--TransferredToRedeemableNciOnConsolidation_iN_pn3n3_di_zj2LvEpqbzml" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Less: Transferred to Redeemable Noncontrolling Interest (“NCI”) pursuant to Business Combination</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(4,465</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--LessParValueOfClassOrdinarySharesIssued_iN_pn3n3_di_zcGfGfzQwHqa" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less: Par value of Class A ordinary shares issued</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--NetChargeToAdditionalPaidincapitalAsResultOfBusinessCombinationReportedInStockholdersDeficit_iN_pn3n3_di_zVlaNUZ29Yr6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net charge to Additional paid-in-capital as a result of the Business Combination reported in Shareholders’ equity (deficit)</td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(38,492</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td style="width: 0in"></td> <td style="width: 0.25in; text-align: left"><span id="xdx_F03_zjTSobWgSX9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F1C_zoKjnXMHuJTi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes liability pursuant to warrants and Forward Purchase Agreements. Refer Note 20 for details</span></td> </tr> </table> <p id="xdx_8AD_zw49Ocm20X4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Business Combination, the Company’s Class A ordinary shares trades under the ticker symbol “AERT” and its public warrants (the “Public Warrants”) trade under the ticker symbol “AERTW” on the Nasdaq Stock Market. Prior to the consummation of the Business Combination, the Company’s Class A ordinary shares were traded on the Nasdaq Stock Market under the symbol “WWAC.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21027801	shares
CY2024Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3697000	usd
CY2024Q1	aert	Public Shareholders Redeemable Class Ordinary Shares Including Bonus Shares PublicShareholdersRedeemableClassOrdinarySharesIncludingBonusShares	3157469	shares
CY2024Q1	aert	Shares Held By Worldwide Webb Acquisition Sponsor Llc Sponsor And Other Initial Holders SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders	2750000	shares
CY2024Q1	aert	Shares Held By Innovo Consultancy Dmcc SharesHeldByInnovoConsultancyDmcc	5638530	shares
CY2024Q1	aert	Shares Held By Fpa Holders SharesHeldByFpaHolders	3711667	shares
CY2024Q1	us-gaap	Shares Issued SharesIssued	15257666	shares
CY2024	aert	Balance In Company Trust Account BalanceInCompanyTrustAccount	40402000	usd
CY2024	aert	Outflow On Account Of Redemption Payments OutflowOnAccountOfRedemptionPayments	18795000	usd
CY2024	aert	Prepayment For Recycle Share Under Forward Purchase Agreement PrepaymentForRecycleShareUnderForwardPurchaseAgreement	3083000	usd
CY2024	aert	Less Payments Under Nonredemption Agreements LessPaymentsUnderNonredemptionAgreements	9672000	usd
CY2024	aert	Payment To Continental Stock Transfer For Services Provided In Relation To Business Combination PaymentToContinentalStockTransferForServicesProvidedInRelationToBusinessCombination	186000	usd
CY2024	aert	Net Cash Acquired In Business Combination NetCashAcquiredInBusinessCombination	8666000	usd
CY2024	aert	Assumed Net Liabilities Of Ati On Closing Date AssumedNetLiabilitiesOfAtiOnClosingDate	38994000	usd
CY2024	aert	Precombination Transaction Costs PrecombinationTransactionCosts	3697000	usd
CY2024	aert	Transferred To Redeemable Nci On Consolidation TransferredToRedeemableNciOnConsolidation	4465000	usd
CY2024	aert	Less Par Value Of Class Ordinary Shares Issued LessParValueOfClassOrdinarySharesIssued	2000	usd
CY2024	aert	Net Charge To Additional Paidincapital As Result Of Business Combination Reported In Stockholders Deficit NetChargeToAdditionalPaidincapitalAsResultOfBusinessCombinationReportedInStockholdersDeficit	38492000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1914000	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2084000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zPA1zv7jY5cd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zRjCptQoBqfj">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, revenue recognition, allowance for credit losses, stock-based compensation, fair valuation of Forward Purchase Agreements (“FPAs”) put option liabilities and private warrant liabilities, useful lives of property and equipment, accounting for income taxes, determination of incremental borrowing rates used for operating lease liabilities and right-of-use assets, obligations related to employee benefits and carve-out of financial statements, including the allocation of assets, liabilities and expenses. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to the Company at the time that these estimates and judgments were made. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	aert	Redemption Shares RedemptionShares	288333	shares
CY2024Q1	aert	Prepayment Amount PrepaymentAmount	42760000	usd
CY2024	aert	Underlying Consideration Amount UnderlyingConsiderationAmount	39678000	usd
CY2024	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p id="xdx_84C_eus-gaap--DerivativesMethodsOfAccountingNonhedgingDerivatives_zWBCmtbuKaA" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zA5E1ACQh173">Derivative Financial Instruments and FPA Put Option Liability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the Warrants (defined below) in accordance with the guidance contained in ASC 815-40 under which the Instruments (as defined below) do not meet the criteria for equity treatment and must be recorded as liabilities. The Company accounts for the FPA put option liability as a financial liability in accordance with the guidance in ASC 480-10. Warrants and FPA are collectively referred as the “Instruments”. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations. See Note 18 for further discussion of the pertinent terms of the Warrants and Note 20 for further discussion of the methodology used to determine the value of the instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the Company settled vendor balances amounting to $<span id="xdx_90E_ecustom--SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors_pn3n3_c20231201__20231231_zpmKVHrEtxYd" title="Settlement of accounts payable through issuance of Class A ordinary shares to vendors">855</span> owed to certain vendors by issuing <span id="xdx_902_eus-gaap--SharesIssued_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Shares issued">361,338</span> Class A ordinary shares. If the VWAP of the Class A ordinary shares over the three trading days immediately preceding the agreement date is higher than the VWAP over the three trading days immediately preceding the six-month anniversary from the agreement date, additional Class A ordinary shares of ATI would need to be issued for the difference. This represents a derivative financial instrument written by the Company which has been accounted for in accordance with the guidance contained in ASC 815-40 including subsequent re-measurement at fair value with the changes being recognized in Company’s consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value at inception and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the consolidated balance sheets as current or noncurrent based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	aert	Settlement Of Accounts Payable Through Issuance Of Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors	855000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zyfobTNIQSed" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zO058xzMNXve">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, accounts receivable, loans to affiliates, and investments. The Company holds cash at financial institutions that the Company believes are high credit quality financial institutions and limits the amount of credit exposure with any one bank and conducts ongoing evaluations of the creditworthiness of the banks with which it does business. As of March 31, 2024 and March 31, 2023, there were one and four customers, respectively, that represented 10% or greater of the Company’s accounts receivable balance. The Company expects limited credit risk arising from its long-term investments as these primarily entail investments in the Company’s affiliates that have a credit rating that is above the minimum allowable credit rating defined in the Company’s investment policy. As a part of its risk management process, the Company limits its credit risk with respect to long-term investments by performing periodic evaluations of the credit standing of counterparties to its investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In respect of the Company’s revenue, there were two and four customers that each accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20230401__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20230401__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20220401__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_pdd" title="Concentration of credit risk, percentage">10%</span></span></span></span> of total revenue for the year ended March 31, 2024 and 2023, respectively. The following table shows the amount of revenue derived from each customer exceeding <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20230401__20240331__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20220401__20230331__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration of credit risk, percentage">10%</span></span> of the Company’s revenue during the year ended March 31, 2024 and 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCededCreditRiskByReinsurerTextBlock_pn3n3_zw1jYAYwle46" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span id="xdx_8B8_zp9zGQ65EzOf" style="display: none">Schedule of concentration of credit risk</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> March 31,</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 1</span></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20240331__srt--MajorCustomersAxis__custom--CustomerOneMember_zgsQZE2AASLh" title="Concentration of credit risk, percentage">14</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember_z6x8tsjeV72f" title="Concentration of credit risk, percentage">16</span></td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 2</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20240331__srt--MajorCustomersAxis__custom--CustomerTwoMember_zbGEkYqNAVTj" title="Concentration of credit risk, percentage">12</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8sy7QbdcT96" title="Concentration of credit risk, percentage">16</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 3</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__srt--MajorCustomersAxis__custom--CustomerThreeMember_zzCdKsc5u2Ib" title="Concentration of credit risk, percentage">12</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 4</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20230331__srt--MajorCustomersAxis__custom--CustomerFourMember_zcemjFlvS3c5" title="Concentration of credit risk, percentage">11</span></td> <td style="text-align: left">%</td></tr> </table> <p id="xdx_8A3_z4fBXyytJNoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1263000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	3697000	usd
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	1921000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	663000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	568000	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	aert	Employee Benefit Plan EmployeeBenefitPlan	796000	usd
CY2023	aert	Employee Benefit Plan EmployeeBenefitPlan	642000	usd
CY2024Q1	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	2537000	usd
CY2023Q1	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	1910000	usd
CY2024	aert	Schedule Net Income Attributable To Noncontrolling Interest ScheduleNetIncomeAttributableToNoncontrollingInterest	<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleNetIncomeAttributableToNoncontrollingInterest_pn3n3_zHvaaVQfYosa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Restatement of Previously Issued Carve-out Consolidated Financial Statements (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B4_zUXCEnwZb41b" style="display: none">Schedule of unaudited consolidated financial information</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49E_20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_ziaNUbeuo8sj" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49C_20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zBURlEK7QMR3" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_498_20230331__srt--RestatementAxis__custom--AsAdjustedRestateementsNo1Member_z1wXVAPnF07d" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">As Previously<br/> Reported</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">As Adjusted Restatement no. 1</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Restatement<br/> Adjustment</b></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31,<br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Carve-out Consolidated Balance Sheet</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Net stockholder’s investment and additional paid-in capital</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,311</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(90</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,221</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_zc570RHhb0Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Retained earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,454</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(136</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,318</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accumulated other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,385</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,349</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--StockholdersEquity_iI_pn3n3_zcEACDXiea8e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total Aark Singapore Pte. Ltd. stockholder’s equity</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">12,380</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(190</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">12,190</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--MinorityInterest_iI_pn3n3_zV2jj8ScbtC2" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Noncontrolling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,089</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,279</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iI_pn3n3_zLc5bqVKOVWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total stockholder’s equity</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">13,469</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">13,469</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pn3n3_zDfTZu2CfLvb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total liabilities and stockholder’s equity</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">34,397</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1118">-</span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">34,397</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Carve-out Consolidated Statement of Operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Net income attributable to noncontrolling interest</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_c20220401__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pn3n3" style="text-align: right" title="Less: Net income attributable to noncontrolling interests">221</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_c20220401__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pn3n3" style="text-align: right" title="Less: Net income attributable to noncontrolling interests">39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20230331__srt--RestatementAxis__custom--AsAdjustedRestateementsNo1Member_zf03MDlkPL5f" style="text-align: right" title="Less: Net income attributable to noncontrolling interests">260</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net income attributable to Aark Singapore Pte. Ltd.</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220401__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHAAas54VRrd" style="font-weight: bold; text-align: right">1,485</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220401__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_pn3n3" style="font-weight: bold; text-align: right">(39</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220401__20230331__srt--RestatementAxis__custom--AsAdjustedRestateementsNo1Member_zKoWx2WMY9Sk" style="font-weight: bold; text-align: right">1,446</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Carve-out Consolidated Statement of Comprehensive Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Comprehensive income attributable to noncontrolling interest</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ComprehensiveIncomeAttributableToNoncontrollingInterests_pn3n3_c20220401__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOFxKfXlESO5" style="text-align: right" title="Comprehensive income attributable to noncontrolling interest">118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--ComprehensiveIncomeAttributableToNoncontrollingInterests_pn3n3_c20220401__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwbc340b4zic" style="text-align: right" title="Comprehensive income attributable to noncontrolling interest">21</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--ComprehensiveIncomeAttributableToNoncontrollingInterests_pn3n3_c20220401__20230331__srt--RestatementAxis__custom--AsAdjustedRestateementsNo1Member_z2YVkWRMvvoa" style="text-align: right" title="Comprehensive income attributable to noncontrolling interest">139</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total comprehensive income attributable to Aark Singapore Pte. Ltd.</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220401__20230331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zLMg1tau0Z08" style="font-weight: bold; text-align: right" title="Total comprehensive income attributable to Aark Singapore Pte. Ltd.">762</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220401__20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1ga6zvgCnmf" style="font-weight: bold; text-align: right" title="Total comprehensive income attributable to Aark Singapore Pte. Ltd.">(21</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTax_pn3n3_c20220401__20230331__srt--RestatementAxis__custom--AsAdjustedRestateementsNo1Member_zqifxC3qXbMg" style="font-weight: bold; text-align: right" title="Total comprehensive income attributable to Aark Singapore Pte. Ltd.">741</td><td style="font-weight: bold; text-align: left"> </td></tr> </table>
CY2024Q1	aert	Advance Nonincome Taxes AdvanceNonincomeTaxes	4179000	usd
CY2023Q1	aert	Advance Nonincome Taxes AdvanceNonincomeTaxes	3371000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	878000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	405000	usd
CY2024Q1	aert	Advance To Vendors AdvanceToVendors	728000	usd
CY2023Q1	aert	Advance To Vendors AdvanceToVendors	119000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	424000	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	29000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	786000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	193000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6995000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4117000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7758000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6040000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4179000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2915000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3579000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3125000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-54000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1352000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1172000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	815000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	955000	usd
CY2024Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	797000	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	609000	usd
CY2024Q1	aert	Heldtomaturity Investments Net Carrying Amount HeldtomaturityInvestmentsNetCarryingAmount	1612000	usd
CY2023Q1	aert	Heldtomaturity Investments Net Carrying Amount HeldtomaturityInvestmentsNetCarryingAmount	1564000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	3584000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2257000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	294000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	308000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4892000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1319000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	261000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	193000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	257000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	124000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9288000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4201000	usd
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	6778000	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1376000	usd
CY2024	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0080	pure
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0120	pure
CY2024	aert	Insurance For Its Directors InsuranceForItsDirectors	After the Closing Date, ATI obtained an insurance policy for its directors and senior officers with maximum coverage of $5,000. The total premium payable in relation to this was $880 out of which $176 was paid upfront and balance $704 is payable in ten equal monthly instalments of $73. The arrangement represents a financing transaction where the premium payable has been deferred. The interest rate under the arrangement is 9.2 % per annum. The cumulative interest payable throughout the tenure under the arrangement amounts to $30 and the same would be recognized as part of the interest expense in the consolidated statement of operations. During the year ended March 31, 2024, the interest expense so recognized was $22. The balance premium payable as at March 31, 2024 is $432 and has been disclosed as a current liability since ATI has an unconditional obligation to settle it by September 2024.
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1440000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	969000	usd
CY2022Q4	aert	Exchange Rate ExchangeRate	137000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1075	pure
CY2023Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P48M
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	13000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	849000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	591000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1453000	usd
CY2024Q1	aert	Accrued Compensation And Related Benefits AccruedCompensationAndRelatedBenefits	3777000	usd
CY2023Q1	aert	Accrued Compensation And Related Benefits AccruedCompensationAndRelatedBenefits	2764000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	162000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	235000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	9000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	9000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3948000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3008000	usd
CY2024	us-gaap	Revenues Revenues	72509000	usd
CY2023	us-gaap	Revenues Revenues	53099000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	255000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2024	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	193000	usd
CY2023	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	228000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	261000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	193000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2023Q1	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	1357000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	908000	usd
CY2024	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	98000	usd
CY2023	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	52000	usd
CY2024	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	449000	usd
CY2023	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	338000	usd
CY2024	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	68000	usd
CY2023	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	218000	usd
CY2024	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	47000	usd
CY2023	us-gaap	Defined Benefit Plan Plan Assets Benefits Paid DefinedBenefitPlanPlanAssetsBenefitsPaid	78000	usd
CY2024	aert	Effect Of Exchange Rate Fluctuation EffectOfExchangeRateFluctuation	19000	usd
CY2023	aert	Effect Of Exchange Rate Fluctuation EffectOfExchangeRateFluctuation	81000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	1906000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	1357000	usd
CY2024	aert	Recorded In Accrued Compensation And Related Benefits Current RecordedInAccruedCompensationAndRelatedBenefitsCurrent	203000	usd
CY2023	aert	Recorded In Accrued Compensation And Related Benefits Current RecordedInAccruedCompensationAndRelatedBenefitsCurrent	120000	usd
CY2024	aert	Recorded In Other Liabilities RecordedInOtherLiabilities	1701000	usd
CY2023	aert	Recorded In Other Liabilities RecordedInOtherLiabilities	1237000	usd
CY2024	aert	Total Project Benefit Obligation TotalProjectBenefitObligation	-1904000	usd
CY2023	aert	Total Project Benefit Obligation TotalProjectBenefitObligation	-1357000	usd
CY2024	aert	Accumulated Net Actuarial Loss AccumulatedNetActuarialLoss	501000	usd
CY2023	aert	Accumulated Net Actuarial Loss AccumulatedNetActuarialLoss	516000	usd
CY2024	aert	Accumulated Deferred Income Tax Expense Benefit AccumulatedDeferredIncomeTaxExpenseBenefit	-126000	usd
CY2023	aert	Accumulated Deferred Income Tax Expense Benefit AccumulatedDeferredIncomeTaxExpenseBenefit	-129000	usd
CY2024	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Loss Net Gain Loss Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax	375000	usd
CY2023	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Loss Net Gain Loss Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax	387000	usd
CY2024	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	68000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	218000	usd
CY2024	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	85000	usd
CY2023	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	62000	usd
CY2024	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	5000	usd
CY2023	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	-39000	usd
CY2024	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	-12000	usd
CY2023	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	117000	usd
CY2024	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	449000	usd
CY2023	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	338000	usd
CY2024	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	98000	usd
CY2023	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	52000	usd
CY2024	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	85000	usd
CY2023	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	62000	usd
CY2024	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	632000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	452000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0828	pure
CY2023Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.0731	pure
CY2024Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.1000	pure
CY2023Q1	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease	0.1000	pure
CY2024Q1	aert	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Employee Turnover DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfEmployeeTurnover	0.2000	pure
CY2023Q1	aert	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Employee Turnover DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfEmployeeTurnover	0.2000	pure
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	203000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	278000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	376000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	524000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	634000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	3053000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19127000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2766000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2589000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1221000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-718000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-161000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1871000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1060000	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1871000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1060000	usd
CY2024	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	4000	usd
CY2023	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	-39000	usd
CY2024	aert	Income Tax Expense IncomeTaxExpense	1875000	usd
CY2023	aert	Income Tax Expense IncomeTaxExpense	1021000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19127000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2766000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	470000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	383000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	241000	usd
CY2024	aert	Income Tax Reconciliation Reversal Of Deferred Tax Asset Liability IncomeTaxReconciliationReversalOfDeferredTaxAssetLiability	7000	usd
CY2023	aert	Income Tax Reconciliation Reversal Of Deferred Tax Asset Liability IncomeTaxReconciliationReversalOfDeferredTaxAssetLiability	36000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	36000	usd
CY2024	aert	Income Tax Reconciliation Tax Of Earlier Year IncomeTaxReconciliationTaxOfEarlierYear	221000	usd
CY2023	aert	Income Tax Reconciliation Tax Of Earlier Year IncomeTaxReconciliationTaxOfEarlierYear	9000	usd
CY2024	aert	Income Tax Reconciliation True Up Down IncomeTaxReconciliationTrueUpDown	78000	usd
CY2023	aert	Income Tax Reconciliation True Up Down IncomeTaxReconciliationTrueUpDown	89000	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3000	usd
CY2024	aert	Effective Income Tax Rate Reconciliation Nondeductible Expense Adjustments For Change In Rates Due To Different Tax Jurisdiction EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAdjustmentsForChangeInRatesDueToDifferentTaxJurisdiction	1254000	usd
CY2023	aert	Effective Income Tax Rate Reconciliation Nondeductible Expense Adjustments For Change In Rates Due To Different Tax Jurisdiction EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAdjustmentsForChangeInRatesDueToDifferentTaxJurisdiction	223000	usd
CY2024	aert	Effective Income Tax Rate Reconciliation Set Off Against Brought Forward Losses EffectiveIncomeTaxRateReconciliationSetOffAgainstBroughtForwardLosses	-60000	usd
CY2023	aert	Effective Income Tax Rate Reconciliation Set Off Against Brought Forward Losses EffectiveIncomeTaxRateReconciliationSetOffAgainstBroughtForwardLosses	-60000	usd
CY2024	aert	Income Tax Reconciliation Gilti Inclusion IncomeTaxReconciliationGiltiInclusion	42000	usd
CY2023	aert	Income Tax Reconciliation Gilti Inclusion IncomeTaxReconciliationGiltiInclusion	27000	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-56000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1871000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1060000	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0978	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.3833	pure
CY2024Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	1933000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	1237000	usd
CY2024Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	92000	usd
CY2023Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	168000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1841000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1069000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	40000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	79000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	295565	shares
CY2024	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y6M
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.4080	pure
CY2024	aert	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionRiskFreeInterestRate	0.0301	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2024	aert	Stock Based Compensation Expense StockBasedCompensationExpense	1626000	usd
CY2023	aert	Stock Based Compensation Expense StockBasedCompensationExpense	3805000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2024	aert	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	0	usd
CY2023	aert	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	1706000	usd
CY2024	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	398000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	386000	usd
CY2024	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	70000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	65000	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	2795000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2273000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8000	usd
CY2024	us-gaap	Lease Cost LeaseCost	3263000	usd
CY2023	us-gaap	Lease Cost LeaseCost	2732000	usd
CY2024	aert	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	2681000	usd
CY2023	aert	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	2162000	usd
CY2024	aert	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	70000	usd
CY2023	aert	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	65000	usd
CY2024	aert	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	391000	usd
CY2023	aert	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	390000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y8M15D
CY2023Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y10M24D
CY2024Q1	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P1Y8M1D
CY2023Q1	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P1Y10M6D
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.1070	pure
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.1065	pure
CY2024Q1	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1260	pure
CY2023Q1	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1056	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9248000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	494000	usd
CY2024Q1	aert	Gross Lease Liabilities GrossLeaseLiabilities	9742000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1553000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	38000	usd
CY2024Q1	aert	Less Imputed Interest LessImputedInterest	1591000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	7695000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	456000	usd
CY2024Q1	aert	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	8151000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2080000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	294000	usd
CY2024Q1	aert	Current Portion Of Lease Liabilities CurrentPortionOfLeaseLiabilities	2374000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5615000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	162000	usd
CY2024Q1	aert	Longterm Lease Liabilities LongtermLeaseLiabilities	5777000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2743000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	324000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2423000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	155000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1944000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	15000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1419000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	719000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9248000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	494000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1553000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	38000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	7695000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	456000	usd
CY2024	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	200000	shares
CY2024Q1	aert	Exchange Rate ExchangeRate	2399000	usd
CY2023Q1	aert	Exchange Rate ExchangeRate	2433000	usd
CY2024	us-gaap	Other Noncash Income OtherNoncashIncome	2000	usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	12000	usd
CY2024	aert	Initial Public Offering Description InitialPublicOfferingDescription	the consummation of the Initial Public Offering (IPO), the Company issued 11,499,991 Public Warrants. Simultaneously with the closing of the IPO, WWAC issued 8,900,000 warrants in a private placement (the “Private Placement Warrants”), at a purchase price of $1.00 per Private Placement Warrant, which included 900,000 Units as a result of the underwriter’s full exercise of its option to purchase up to 900,000 additional warrants, at a purchase price of $1.00 per Private Placement Warrant. On November 6, 2023, WWAC issued 627,810 other Private Placement Warrants to the Sponsor pursuant to the conversion of a promissory note payable to the Sponsor. Upon consummation of the Business Combination, the Company assumed 11,499,991 Public Warrants and 9,527,810 Private Placement Warrants (collectively the “Warrants”).
CY2024Q1	aert	Sale Price SalePrice	18.00
CY2023Q1	aert	Sale Price SalePrice	18.00
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2024	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	10000	shares
CY2024	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRepurchaseAgreements_pn3n3_zJWMjNouhjN8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B3_zarBEbHkV9Q1" style="display: none">Schedule of purchase agreement</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> March 31,</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted Average Fair Value</td> <td> </td> <td colspan="6" style="text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pn3n3_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zJXQRuBctm2" title="Weighted Average Fair Value">10,244</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 76%">Expected Term (Years)</td> <td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td> <td style="text-align: right; width: 9%"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zSlnEFkfvWod" title="Expected Term (Years)">0.60</span></td> <td style="text-align: left; width: 1%"> </td> <td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td> <td style="text-align: right; width: 9%"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zOpR6W4kiwp1" title="Expected Term (Years)">0.60</span></td> <td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk free Interest Rate</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zRELgLBgfXhg" title="Risk-free interest rate">5.10</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zPX8X4MMQKSb" title="Risk-free interest rate">5.10</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Volatility</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_ziopqMy6KgR9" title="Volatility">39.0</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zYLDJ6ZJy9pj" title="Volatility">39.0</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reference Price for one share of Class A common stock</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_901_ecustom--ReferencePriceForOneShareOfClassCommonStock_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_pdd" title="Reference Price for one share of Class A common stock">10.69</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_903_ecustom--ReferencePriceForOneShareOfClassCommonStock_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_pdd" title="Reference Price for one share of Class A common stock">2.21</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Probability (Weight) - No Dilutive Offering Reset / With Dilutive Offering Reset due to PIPE transaction</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90E_ecustom--ProbabilityWeightNoDilutiveOfferingResetWithDilutiveOfferingResetDueToPipeTransaction_pid_dp_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_fKk5vdGU6_z5v1BXf1P7p4" title="Probability (Weight) - No Dilutive Offering Reset / With Dilutive Offering Reset due to PIPE transaction">5</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_907_ecustom--ProbabilityWeightNoDilutiveOfferingResetWithDilutiveOfferingResetDueToPipeTransaction_pid_dp_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_fKk5vdGU6_z7x4Y0Aq1nt6" title="Probability (Weight) - No Dilutive Offering Reset / With Dilutive Offering Reset due to PIPE transaction">95</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair Value of Forward Purchase Agreement Put Option Liability [in thousands]</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_90F_ecustom--FairValueOfForwardPurchaseAgreementPutOptionLiability_pn3n3_c20230401__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zA9G4NcbMeAa" title="Fair Value of Forward Purchase Agreement Put Option Liability">40,880</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_903_ecustom--FairValueOfForwardPurchaseAgreementPutOptionLiability_pn3n3_c20220401__20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_z3IVcDNdpg0c" title="Fair Value of Forward Purchase Agreement Put Option Liability">8,631</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock price at measurement date</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_904_ecustom--StockPriceAtMeasurementsDate_pip0_c20230401__20240331_zdt1jUc9doP8" title="Stock price at measurement date">2.6</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_901_ecustom--StockPriceAtMeasurementsDate_pip0_c20220401__20230331_zsHhhAXqFGn4" title="Stock price at measurement date">2.6</span></td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify; border-collapse: collapse"> <td id="xdx_F0F_zesi0VmZ6yz7" style="width: 0.5in; text-align: left">Note:</td> <td id="xdx_F17_zbTtmNVYAV41" style="text-align: justify">The private placement announced and completed on April 8, 2024 (estimated probability of 95% as of March 31, 2024). Quoted share price of common stock of the Company when PIPE (Private Investment in Public Entity) transaction took place was $2.21 approx.</td> </tr> </table>
CY2024	aert	Stock Price At Measurements Date StockPriceAtMeasurementsDate	2.6
CY2023	aert	Stock Price At Measurements Date StockPriceAtMeasurementsDate	2.6
CY2024	aert	Warrants And Forward Purchase Agreement Put Option Liability Acquired As Part Of Business Combination WarrantsAndForwardPurchaseAgreementPutOptionLiabilityAcquiredAsPartOfBusinessCombination	27778000	usd
CY2024	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-16167000	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	11611000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14154000	usd
CY2024	aert	Weighted Average Shares Outstanding Of Class Ordinary Shares Basic And Diluted WeightedAverageSharesOutstandingOfClassOrdinarySharesBasicAndDiluted	15532382	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.91

Files In Submission

Name	View Source	Status
0001829126-24-006527-index-headers.html	Edgar Link	pending
0001829126-24-006527-index.html	Edgar Link	pending
0001829126-24-006527.txt	Edgar Link	pending
0001829126-24-006527-xbrl.zip	Edgar Link	pending
aeriestech_10k.htm	Edgar Link	pending
aeriestech_ex10-17.htm	Edgar Link	pending
aeriestech_ex10-19.htm	Edgar Link	pending
aeriestech_ex10-21.htm	Edgar Link	pending
aeriestech_10k_htm.xml	Edgar Link	completed
aeriestech_ex10-23.htm	Edgar Link	pending
aeriestech_ex10-25.htm	Edgar Link	pending
aeriestech_ex10-27.htm	Edgar Link	pending
aeriestech_ex10-45.htm	Edgar Link	pending
aeriestech_ex10-46.htm	Edgar Link	pending
aeriestech_ex10-47.htm	Edgar Link	pending
aeriestech_ex10-48.htm	Edgar Link	pending
aeriestech_ex21-1.htm	Edgar Link	pending
aeriestech_ex23-1.htm	Edgar Link	pending
aeriestech_ex31-1.htm	Edgar Link	pending
aeriestech_ex31-2.htm	Edgar Link	pending
aeriestech_ex32-1.htm	Edgar Link	pending
aeriestech_ex32-2.htm	Edgar Link	pending
aeriestech_ex4-4.htm	Edgar Link	pending
aeriestech_ex97-1.htm	Edgar Link	pending
aert-20240331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
aert-20240331_cal.xml	Edgar Link	unprocessable
aert-20240331_def.xml	Edgar Link	unprocessable
aert-20240331_pre.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
aert-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AERT
Aeries Technology, Inc. Stock $aert

2024 Q3 Form 10-K Financial Statement

#000182912624006527 Filed on September 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT Aeries Technology, Inc. Stock $aert

2024 Q3 Form 10-K Financial Statement

#000182912624006527 Filed on September 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT
Aeries Technology, Inc. Stock $aert